CRISPR Therapeutics crisprtx.com


Public list: Smart Money VCs (6328) Synthetic Biology (137) Pharma Startups (4732)

Crispr Therapeutics is a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into medicines for serious diseases, based on foundational patent estate licensed from scientific founder Emmanuelle Charpentier, Ph.D. (who co-invented the application of CRISPR/Cas9 for gene editing).

Crispr Therapeutics is a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into medicines for serious diseases, based on foundational patent estate licensed from scientific founder Emmanuelle Charpentier, Ph.D. (who...Show all

Company (IPO / Went public)

Phone: 617-315-4600

Fax:

200 Sidney Street

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CRISPR Therapeutics $218M Oct 19, 2016
See all 4 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CRISPR Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors
See all 4 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Materials and methods for treatment of hemoglobinopathies Feb 23, 2016 Application
Materials and methods for treatment of hemoglobinopathies Feb 23, 2016 Application
Crispr-cas system materials and methods Nov 17, 2014 Application